Medical imaging has transformed modern healthcare, enabling doctors to detect diseases earlier, monitor treatment progress, and avoid unnecessary surgeries. From routine chest X-rays to advanced magnetic resonance imaging (MRI) and computed tomography (CT) scans, these tools are now integral to clinical decision-making across the globe. Though, as imaging technology becomes more accessible and frequently used, growing attention is being paid to the potential downsides — not just financial costs, but also radiation exposure, overdiagnosis, and the psychological impact of false alarms.
The balance between benefit and harm in medical imaging is no longer a theoretical concern for specialists alone. It is a pressing public health issue affecting patients, clinicians, and healthcare systems worldwide. Recent data from the World Health Organization (WHO) indicates that medical imaging procedures have increased by more than 20% globally over the past decade, with particularly sharp rises in high-income countries. In the United States alone, nearly 80 million CT scans are performed annually, according to the U.S. Food and Drug Administration (FDA), raising questions about cumulative radiation exposure and long-term cancer risks.
This growing scrutiny has prompted medical professionals and policymakers to reevaluate how imaging is used — not to reject its value, but to optimize it. The goal is not to reduce necessary scans, but to eliminate those that offer little clinical benefit while exposing patients to avoidable risks. As Dr. Rebecca Smith-Bindman, a professor of radiology and biomedical imaging at the University of California, San Francisco, stated in a 2023 interview with The Lancet: “We must shift from a culture of ‘just in case’ imaging to one of ‘right test, right time, right patient.’”
Central to this effort is the concept of appropriateness criteria — evidence-based guidelines that help clinicians determine when a specific imaging test is warranted. In the United States, the American College of Radiology (ACR) maintains the Appropriateness Criteria®, a continuously updated framework that ranks the suitability of various imaging procedures for specific clinical scenarios on a scale from 1 (usually not appropriate) to 9 (usually appropriate). Similar initiatives exist in Europe through the European Society of Radiology (ESR) and in Canada via the Canadian Association of Radiologists (CAR).
These guidelines are increasingly being integrated into electronic health record (EHR) systems, where they can prompt physicians to consider alternatives before ordering a scan. For example, when a doctor enters a request for a lumbar spine MRI for uncomplicated low back pain lasting less than six weeks, the system may flag that such imaging is rarely appropriate and suggest physical therapy or analgesics as first-line options. Studies have shown that such clinical decision support tools can reduce inappropriate imaging by up to 30%, according to a 2022 systematic review published in JAMA Internal Medicine.
Radiation exposure remains one of the most tangible risks associated with certain imaging modalities, particularly CT and fluoroscopy. While a single chest X-ray delivers about 0.1 millisievert (mSv) of radiation — roughly equivalent to 10 days of natural background exposure — a single abdominal CT scan can deliver 10 mSv or more, comparable to several years of background radiation. Although the risk from any single scan is tiny, population-level models suggest that widespread overuse could contribute to a measurable number of future cancer cases. The National Cancer Institute (NCI) estimates that up to 2% of all future cancers in the United States could be attributable to radiation from CT scans, based on current usage patterns.
Children are especially vulnerable to radiation-related risks due to their developing tissues and longer lifespans over which potential harm could manifest. In response, initiatives like the Image Gently campaign, led by the Alliance for Radiation Safety in Pediatric Imaging, have promoted child-specific protocols that reduce radiation doses without compromising diagnostic quality. Since its launch in 2008, the campaign has contributed to a measurable decline in pediatric CT utilization in participating hospitals, according to data from the Pediatric Emergency Care Applied Research Network (PECARN).
Beyond radiation, another significant concern is overdiagnosis — the detection of abnormalities that would never have caused symptoms or harm during a person’s lifetime. This is particularly relevant in screening contexts, such as mammography for breast cancer or low-dose CT for lung cancer in high-risk individuals. While these screenings save lives by catching aggressive cancers early, they also identify indolent lesions that may lead to unnecessary biopsies, surgeries, and anxiety. A 2021 analysis by the Cochrane Collaboration found that for every 2,000 women screened regularly with mammography over 10 years, one life is prolonged, but approximately 10 women undergo unnecessary treatment.
Psychological consequences also merit attention. False-positive results — where an initial scan suggests abnormality that later proves benign — can trigger significant distress, even when follow-up testing ultimately rules out disease. A study published in Health Psychology in 2020 found that patients who received false-positive mammogram results reported elevated anxiety levels comparable to those diagnosed with actual cancer, with effects persisting for months after resolution.
Economic costs further complicate the equation. In many countries, medical imaging accounts for a growing share of healthcare expenditures. In Germany, where statutory health insurance covers most imaging procedures, spending on diagnostic radiology rose by over 40% between 2010 and 2020, according to the Federal Statistical Office (Destatis). While such investments reflect advances in care, they also raise questions about opportunity cost — whether funds might be better allocated to preventive care, chronic disease management, or primary care access in underserved communities.
Efforts to strike a better balance are underway on multiple fronts. Professional organizations are emphasizing shared decision-making, encouraging doctors to discuss the potential benefits, risks, and alternatives with patients before proceeding with imaging. Tools like the Option Grid™, developed by researchers at Dartmouth College and now used in clinics across Europe and North America, provide structured conversation aids to help patients weigh choices such as whether to pursue an MRI for suspected meniscal tear or try physical therapy first.
Public awareness campaigns are also gaining traction. In the United Kingdom, the National Health Service (NHS) has incorporated imaging appropriateness into its “Choosing Wisely” initiative, which encourages conversations about tests and treatments where the risks may outweigh the benefits. Similar programs exist in Australia, Japan, and several Scandinavian countries, often supported by medical societies and patient advocacy groups.
Looking ahead, artificial intelligence (AI) holds promise for enhancing both the efficiency and safety of medical imaging. AI algorithms are being developed to assist radiologists in detecting subtle abnormalities, prioritizing urgent cases, and even predicting whether a lesion is likely benign or malignant based on texture, shape, and context. Early studies suggest that AI-assisted interpretation can reduce false positives and improve detection rates, particularly in mammography and lung nodule screening. However, experts caution that AI should augment — not replace — human judgment, and that rigorous validation across diverse populations is essential before widespread deployment.
the future of medical imaging lies not in using less or more, but in using better. As imaging continues to evolve — with innovations like photon-counting CT, ultra-high-field MRI, and molecular imaging becoming more clinically available — the responsibility to ensure appropriateness falls on all stakeholders: clinicians who order tests, radiologists who interpret them, patients who consent to them, and policymakers who shape the systems that govern their use.
The next major step in this effort is the upcoming revision of the European Society of Radiology’s (ESR) Guide on Appropriateness Criteria, scheduled for release in late 2024. This update will incorporate new evidence on emerging technologies and place greater emphasis on equity, sustainability, and patient-centered care. Healthcare professionals and administrators seeking the latest guidance can access the ESR’s official portal, where draft versions are often made available for public comment prior to final publication.
As medical imaging becomes ever more powerful, the challenge remains clear: to harness its life-saving potential while minimizing avoidable harm. By grounding decisions in evidence, engaging patients in dialogue, and continually refining guidelines, healthcare systems can ensure that every scan performed truly serves the interest of those it is meant to help.
We invite our readers to share their experiences with medical imaging — whether as patients, caregivers, or healthcare professionals. Have you ever questioned the necessity of a scan? How did you navigate the decision? Your insights help foster a more informed and compassionate conversation about the role of technology in health. Please leave a comment below or share this article with others who might benefit from a deeper understanding of the benefits and trade-offs involved in medical imaging.
Worth a look